癌症中的NF1变化:精准医学中的治疗含义
Jean-Stéphane Giraud1, Ivan Bièche1,2, Éric Pasmant1,3
1Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Paris, France.
Expert opinion on investigational drugs
|September 25, 2023
概括
神经纤维素瘤类型1 (NF1) 基因变异在各种癌症中被发现. 本综述探讨了针对NF1改变的瘤的向疗法和免疫疗法,强调了创新的治疗策略的必要性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 作为一种瘤抑制剂的NF1基因调节了RAS/MAPK和PI3K-AKT-mTOR通路.
- 生殖系NF1变异导致神经纤维素瘤类型 1;体质NF1变化发生在~5%的零星癌症中.
- 虽然针对NF1相关的良性瘤存在向疗法,但对癌症体内NF1变化的影响尚未研究.
研究的目的:
- 为NF1-改变的癌症提供当前和新兴向疗法和免疫疗法的全面概述.
- 确定研究缺口,并强调需要针对NF1功能丧失的新型治疗策略.
主要方法:
- 关于NF1-改变的癌症治疗的原始文章的PubMed文学评论.
- 包括来自现有临床试验 (ClinicalTrials.gov) 和基因组数据库 (TCGA,HGMD®) 的数据.
主要成果:
- 在体外和体内评估的针对性治疗和免疫治疗对NF1-改变的癌症的概述.
- 在目前的研究中针对的关键信号通路 (RAS/MAPK,PI3K-AKT-mTOR) 的识别.
结论:
- 了解NF1改变的瘤机制对于开发有效的治疗方法至关重要.
- 针对像NF1这样的瘤抑制基因在癌症治疗中构成了重大挑战.
- 重点仍然是途径抑制剂和免疫疗法,需要创新的方法.
关键词:
生物标志物 生物标志物NF1 NF1 是一个字母.在 PI3K-AKT-MTOR 信号通路中.在 RAS/MAP 激酶信号通路中.癌症 癌症 癌症 癌症 癌症免疫疗法 免疫疗法有针对性的治疗方法.更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.8K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
